The effect of Atorvastatin and Cetirizine on the improvement of clinical symptoms of patients with chronic urticaria

Comparison of Atorvastatin versus Cetirizine in the treatment of clinical sign of patient with chronic urticaria

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171030037093N17

Enrollment

120

Registered

2019-08-11

Start date

2019-08-01

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urticaria. Urticaria

Interventions

Intervention 1: Intervention group: The first group received atorvastatin 40 mg once daily once a day. Intervention 2: Intervention group: The second group will receive cetirizine at a dose of 20 mg p

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: Hives longer than 3 months Age over 15 years Satisfaction to participate in the study

Exclusion criteria

Exclusion criteria: People with addiction People with systemic or chronic diseases Pregnancy or breastfeeding Use of corticosteroids and Immunosuppression over the past 6 weeks Use of drugs other than antihistamine Reducing the level of lipid profile from the normal level due to the use of atorvastatin

Design outcomes

Primary

Measure	Time frame
Clinical symptoms of urticaria. Timepoint: Before treatment, every month during treatment and one month after treatment. Method of measurement: With index including DLQI.;Slight clinical symptoms of urticaria. Timepoint: Before treatment, every month during treatment and one month after treatment. Method of measurement: With index including USS.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Ali Zamani

Shahre-kord University of Medical Sciences

zamani.m@skums.ac.ir+98 38 3222 0016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026